Cambient Family Office’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
17,060
+105
+0.6% +$12.1K 0.25% 77
2026
Q1
$2.03M Buy
16,955
+1,438
+9% +$189K 0.28% 70
2025
Q4
$2.11M Buy
+15,517
New +$2.23M 0.3% 67

Other funds holding XYL

Cambient Family Office's XYL Position: Q2 2026 in Review

Cambient Family Office increased its Xylem (XYL) stake by 0.62% in Q2 2026, buying an estimated $12.1K and bringing the position to 17,060 shares worth $2.02M. The position accounts for 0.25% of the portfolio, ranked #77.

Cambient Family Office first reported a position in XYL in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.11M in Q4 2025. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Cambient Family Office held 17,060 shares of Xylem worth $2.02M as of Q2 2026.
  • Cambient Family Office bought 105 Xylem shares in Q2 2026, an estimated $12.1K.
  • Xylem made up 0.25% of Cambient Family Office's portfolio in Q2 2026, its #77 holding.
  • Cambient Family Office first reported a position in Xylem in Q4 2025 and has held it in 3 quarters since.
  • Cambient Family Office's Xylem position peaked at $2.11M in Q4 2025.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Cambient Family Office's 13F filing for Q2 2026, filed 13 Aug 2026.